Acuña-Valerio J, Abundes-Velasco A

Idioma: Español
Referencias bibliográficas: 52
Paginas: 41-46
Archivo PDF: 190.45 Kb.

RESUMEN

La trombólisis intracoronaria se utilizó ampliamente para resolver la trombosis coronaria cuando la angioplastia coronaria no era aún una práctica rutinaria. Posteriormente se observó que la trombólisis sistémica era igual de eficaz y más fácil de llevar a cabo, por lo que el primer método cayó en desuso. La angioplastia coronaria primaria desplazó a la trombólisis sistémica como el tratamiento de elección en los pacientes con infarto con elevación del ST. Recientemente se ha observado que la trombólisis intracoronaria es de utilidad en ciertos contextos, y se piensa que puede tener un papel importante en la prevención y tratamiento del fenómeno de no reflujo y de otras complicaciones embólicas.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)1, Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012; 33 (20): 2569-2619.

2. American College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions, O’Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013; 61 (4): e78-e140.

3. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Eng J Med. 1999; 341 (9): 625-634.

4. Armstrong PW, Gershlick AH, Goldstein P, Wilcox R, Danays T, Lambert Y et al. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. N Eng J Med. 2013; 368 (15): 1379-1387.

5. Bonnefoy E, Steg PJ, Boutitie F, Dubien PY, Lapostolle F, Roncalli J et al. Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: A 5-year follow-up. Eur Heart J. 2009; 30: 1598-606.

6. Nallamothu BK, Fox KA, Kennelly BM, Van de Werf F, Gore FM, Steg PG et al. Relationship of treatment delays and mortality in patients undergoing fibrinolysis and primary percutaneous coronary intervention. The Global Registry of Acute Coronary Events. Heart. 2007; 93: 1552-1555.

7. Pinto D, Frederick P, Chakrabarti AK, Kirtane AJ, Ullman E, Dejam A et al. Infarction patients for percutaneous coronary intervention compared with administration of onsite fibrinolytic declines as delays increase. Circulation. 2011; 124: 2512-2521.

8. Curzen N, Gurbel P, Myat A, Bhatt DL, Redwood SR. ST-segment elevation myocardial infarction 2: what is the optimum adjunctive reperfusion strategy for primary percutaneous coronary intervention? Lancet. 2013; 382: 633-643.

9. Kennedy JW, Ritchie JL, Davis K, Fritz J. Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. N Eng J Med.1983; 309: 1477-1482.

10. Rentrop K, Feit F, Blanke H, Stecy P, Schneider R. Effects of intracoronary nitroglycerin infusion on coronary angiographic patterns and mortality in patients with acute myocardial infarction. N Eng J Med. 1984; 311: 1457-1463.

11. Simoons M, Vos J, Tijssen J, Vermeer F, Verheught F, Kraus XH et al. Long term benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5 year follow up of a trial conducted by the Interuniversity Cardiology Institute of the Netherlands. J Am Coll Cardiol. 1989; 14: 1609-1615.

12. Valantine R, Pitts D, Brooks-Brunnn J, Williams J. Intravenous versus intracoronary streptokinase in acute myocardial infarction. Am J Cardiol. 1985; 55: 309-312.

13. Collen D, Bounameaux H. Coronary thrombolysis with clot-selective plasminogen activators. Herz. 1986; 1: 9-15.

14. Collen D, Topol EJ, Tiefenbrunn AJ, Gold HK, Weisfeldt ML, Sobel BE et al. Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controled trial. Circulation. 1984; 70: 1012-1017.

15. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet. 1988; 332 (8607): 349-360.

16. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators. N Eng J Med. 1993; 329 (10): 673-682.

17. Goudreau E, DiSciascio G, Vetrovec GW. Intracoronary urokinase as an adjunct to percutaneous transluminal coronary angioplasty in patients with complex coronary narrowings or angioplasty-induced complications. Am J Cardiol. 1992; 69 (1): 57-62.

18. Kim JS, Kim JH, Jang HH, Lee YH, Song SG, Park JH et al. Succesful revascularization of coronary artery occluded by massive intracoronary thrombi with alteplase and percutaneous coronary intervention. J Atheroscler Thromb. 2010; 17: 768-770.

19. Tieffenbrun AJ. Intracoronary recombinant tissue-type plasminogen activator (rt-PA). Coron Artery Dis. 1996; 7: 637-640.

20. Tiefenbrunn AJ. Intracoronary thrombolysis. Chest. 1992; 101 (6): 1484-1486.

21. Hasdai D, Garratt KN, Holmes DR Jr, Berger PB, Schwartz RS et al. Coronary angioplasty and intracoronary thrombolysis are of limited efficacy in resolving early intracoronary stent thrombosis. J Am Coll Cardiol. 1996; 28: 361-367.

22. Gulba DC, Daniel WG, Simon R, Jost S, Barthels M, Amende I et al. Role of thrombolysis and thrombin in patients with acute coronary occlusion during percutaneous transluminal coronary angioplasty. J Am Coll Cardiol. 1990; 16: 563-568.

23. Gallagher S, Jian AK, Archbold RA. Intracoronary thrombolytic therapy: a treatment option for failed mechanical thrombectomy. Catheter Cardiovasc Interv. 2012; 80 (5): 835-837.

24. Ruocco NA Jr, Currier JW, Jacobs AK, Ryan TJ, Faxon DP. Experience with low-dose intracoronary recombinant tissue-type plasminogen activator for non acute total occlusions before percutaneous transluminal coronary angioplasty. Am J Cardiol. 1991; 68 (17): 1609-1613.

25. Hartmann JR, McKeever LS, Stamato NJ, Bufalino VJ, Marek JC, Brown AS. Recanalization of chronically occluded aortocoronary saphenous vein bypass grafts by extended infusion of urokinase: Initial results and short-term clinical follow-up. J Am Coll Cardiol. 1991; 18 (6): 1517-1523.

26. Yao SS, Spindola-Franco H, Menegus M, Greenberg M, Goldberger M, Shirani J. Successful intracoronary thrombolysis in cocaine-associated acute myocardial infarction. Catheter Cardiovasc Diagn. 1997; 42: 294-297.

27. Harada M, Akimoto K, Otaka M, Sato K, Oda H, Otsuki M et al. Thrombolytic therapy in Kawasaki disease: a report of four cases. Pediatr Int. 2013; 55: 111-115.

28. Karabay CY, Kocabay G, Kalayci A, Tesar O, Kirma C. “Rescue administration” of intracoronary thrombolytic therapy for drug-eluting stent thrombosis. Herz. 2014; 39 (5): 647-650.

29. Linares-Vicente JA, Lukic A, Ruiz-Arroyo JR, Revilla-Martí P, Sánchez B. Combined intracoronary thrombolysis, thrombus aspiration and mesh-covered stent implantation for organized massive thrombus burden in ectatic coronary. Cardiovasc Interv Ther. 2014; 29: 55-59.

30. Reffelmann T, Kloner RA. The “no-reflow” phenomenon: basic science and clinical correlates. Heart. 2002; 87: 162-168.

31. Niccoli G, Burzotta F, Galiuto L, Crea F. Myocardial no-reflow in humans. J Am Coll Cardiol. 2009; 54: 281-292.

32. Brener SJ, Maehara A, Dizon JM, Fahy M, Witzenbichler B, Parise H et al. Relationship between myocardial reperfusion, infarct size, and mortality: the INFUSE-AMI (intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction) trial. JACC Cardiovasc Interv. 2013; 6: 718-724.

33. Topol EJ, Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation. 2000; 101: 570-580.

34. Cortese B, Michelli A, Picchi A, Limbruno U. Combined, superselective pharmacological management of large coronary thrombus burden. J Invasive Cardiol. 2009; 21: 168-171.

35. Boscarelli D, Vaquerizo B, Miranda-Guardiola F, Arzamendi D, Tizon H, Sierra G et al. Intracoronary thrombolysis in patients with ST-segment elevation myocardial infarction presenting with massive intraluminal thrombus and failed aspiration. Eur Heart J Acute Cardiovasc Care. 2014; Epub ahead of print.

36. Jaffe R, Charron T, Puley G, Dick A, Strauss BH. Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention. Circulation. 2008; 117: 3152-3156.

37. Morishima I, Sone T, Okumura K, Tsuboi H, Kondo J, Mukawa H et al. Angiographic No-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol. 2000; 36: 1202-1209.

38. Ndrepepa G, Tiroch K, Keta D, Fusaro M, Seyfarth M, Pache J et al. Predictive factors and impact of no reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction. Circ Cardiovasc Interv. 2010; 3: 27-33.

39. Zhao S, Qi G, Tian W, Chen L, Sun Y. Effect of intracoronary nitroprusside in preventing no reflow phenomenon during primary percutaneous coronary intervention: a meta-analysis. J Interv Cardiol. 2014; 27: 356-364.

40. Su Q, Li L, Liu Y. Short-term effect of verapamil on coronary no-reflow associated with percutaneous coronary intervention in patients with acute coronary syndrome: a systematic review and meta-analysis of randomized controlled trials. Clin Cardiol. 2013; 36: 11-16.

41. Ozdogru I, Zencir C, Dogan A, Orscelik O, Inanc MT, Celik A et al. Acute effects of intracoronary nitroglycerin and diltiazem in coronary slow flow phenomenon. J Investig Med. 2013; 61: 45-49.

42. Singh M, Shah T, Khosla K, Singh P, Molnar J, Khosla S et al. Safety and efficacy of intracoronary adenosine administration in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials. Ther Adv Cardiovasc Dis. 2012; 6: 101-114.

43. Maluenda G, Ben-Dor I, Delhaye C, Gonzalez MA, Collins SD, Torguson R et al. Clinical experience with a novel intracoronary perfusion catheter to treat no-reflow phenomenon in acute coronary syndromes. J Interv Cardiol. 2010; 23: 109-113.

44. Kapoor N, Yalamanchili V, Siddiqui T, Raza S, Leesar MA. Cardioprotective effect of high-dose intragraft adenosine infusion on microvascular function and prevention of no-reflow during saphenous vein grafts intervention. Catheter Cardiovasc Interv. 2014; 83: 1045-1054.

45. Huang D, Qian J, Ge L, Jin X, Jin H, Ma J et al. Restoration of coronary flow in patients with no-reflow after primary coronary intervention of acute myocardial infarction (RECOVER). Am Heart J. 2012; 164: 394-401.

46. Sezer M, Oflaz H, Gören T, Okçular I, Umman B, Nişanci Y et al. Intracoronary streptokinase after primary percutaneous coronary intervention. N Eng J Med. 2007; 356: 1823-1834.

47. Kelly RV, Crouch E, Krumnacher H, Cohen MG, Stouffer GA. Safety of adjunctive intracoronary thrombolytic therapy during complex percutaneous coronary intervention: initial experience with intracoronary tenecteplase. Catheter Cardiovasc Interv. 2005; 66 (3): 327-332.

48. Clinical experience with intracoronary tissue plasminogen activator: results of a multicenter registry. Intracoronary t-PA Registry Investigators. Catheter Cardiovasc Diagn. 1995; 34: 196-201.

49. Echavarría-Pinto M, Lopes R, Gorgadze T, Gonzalo N, Hernández R, Jiménez-Quevedo P et al. Safety and efficacy of intense antithrombotic treatment and percutaneous coronary intervention deferral in patients with large intracoronary thrombus. Am J Cardiol. 2013; 111 (12): 1745-1750.

50. Carrick D, Oldroyd K, McEntegart M, Haig C, Petrie MC, Eteiba H et al. A randomized trial of deferred stenting versus immediate stenting to prevent no- or slow-reflow in acute ST-segment elevation myocardial infarction (DEFER-STEMI). J Am Coll Cardiol. 2014; 27: 2088-2098.

51. Kim JS, Kim JH, Jang HH, Lee YW, Song SG, Park JH et al. Successful revascularization of coronary artery occluded by massive intracoronary thrombi with alteplase and percutaneous coronary intervention. J Atheroscler Thromb. 2010; 17: 768-770.

52. Escaned J, Echavarría-Pinto M, Gorgadze T. Safety of lone thrombus aspiration without concomitant coronary stenting in selected patients with acute myocardial infarction. EuroIntervention. 2013; 8: 1149-1156.